HONG KONG – Hong Kong Polytechnic University (PolyU) is partnering with two European institutions to establish a life sciences and engineering R&D platform to spearhead applied research.
HONG KONG – JW Therapeutics (Shanghai) Co. Ltd. raised $90 million in a series A financing for the development of its first CD19-directed investigational cancer therapy, JWCAR-029. Investors include prominent names such as Singapore-based Temasek, Sequoia Capital China and Yuanming Capital.
HONG KONG – JW Therapeutics (Shanghai) Co. Ltd. raised $90 million in a series A financing for the development of its first CD19-directed investigational cancer therapy, JWCAR-029. Investors include prominent names such as Singapore-based Temasek, Sequoia Capital China and Yuanming Capital.
HONG KONG – The sheer speed of growth of the biotech and med-tech industries in China has easily outpaced the development of regulation and has led to concerns that too many of the ballooning number of clinical trials in the country fail to meet enrollment targets.
HONG KONG – The sheer speed of growth of the biotech and med-tech industries in China has easily outpaced the development of regulation and has led to concerns that too many of the ballooning number of clinical trials in the country fail to meet enrollment targets.
HONG KONG – Biotech companies that have not yet generated any revenue can seek listing on the Main Board of the Hong Kong Stock Exchange (HKEX). The exchange proposed the new policy Friday as part of the effort to lure more firms to go public, bolstering Hong Kong's biotech development.
